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ABSTRACT
In thls study we compared some propert ies of f ibr lnogens, obtained
from normal adult and cord plasna. Fibrl-nogen preparations were
made under conditions, whlch mlniml-ze proteolytlc breakilown l-n
vltro. We were not able to demonstrate any signif icant dlf ferences
between both purlf ied f ibr lnogens as to the effects of pl l  and
l-onic strength on i ts clott ing propert les, the K- for thrombin,
SDS polyacrylarnlde gelelectrophoresis behaviour 6r carbohydrate
content.
Ilowever, the phosphorus content of cord flbrinogen was 3-4 tlmes
hlgher than that of aclult fibrinogen.
The acceleratiflg effect of calclum on the thronbin clotting tlroe
was more pronounced for newborn cord pl-asma and for purlfied cord
fibrinogen preparations as compared r.rlth adult flbrinogen. Thts
ntght be explained by the higher phosphorus content of the cord
fibrlnogen molecule.
Ttre thronbin clottlng tine of both purlfied adult anil cord flbrl-
nogen was markedly prolonged, when increaslng amounts of fibrino-
gen clegradation product fragment X were addeil to the flbrinogen
solutions u4der condl-tlons with high plt or high lonl-c strength.
At high pll the effect of adding fragment X was more pronounced in
cord fLbrlnogen preparations. Therefore, mixtures of purl f ied
fibrinogen and fragrnent X have several pfoperties in common w"lth
fetal f ibr lnogen.
These observations show, that some of the propert ies that have
been attr ibuted Ln the l l - terature to a dist lnct fetal f ibr inogen
can be caused by the presence of fragment X ln the cord fibrinogen
preparatlons.
Key words: cort l  f ibr inogen, puri f icat l .on, propert ies
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INTRODUCTION
The possible existence of a dist inct fetal f lbr inogen r.ras f i-rst reported by
Burstein and coworkers in 1954 (1). They compared some optical and
mechanical propert ies of clots of newborn and adult f ibrtn and found that a
clot of f ibr in of eewborns was more transparant and l-ess compresslbl-e than
a clot of f lbr ln of adults. The dif ference v/as rel-at ively pronounced at pH
8.6 but hardly detectabl-e at pl l  6.9. Ki inzer (.2) noted that whereas the
level of most clott ing factors was l-ow, the level of f ibr inogen in the
newborn was usually the same as ln the adult,  however Ki inzer also noted
d l f fe rences  in  p roper t ies .
He postulated a functional ly dif ferent f ibr lnogen in the newborn with an
accelerated f ibr lnogen-f ibrin transit lon.
Witt  (3-9) isolated f ibr inogen from human urnbi1l lca1 cord blood.
She found a signif icantly retarded thrombin-catalysed converslon of cord
fibrinogen to f tbrin at pHts around 7. The dif ference was even rnore
pronounced at pI{ 8.5. Electron rnlcroscopic comparison of fetal f ibr in clots
r^ri th those from adults showed shorter and thinner f lbers, whlch rnight be a
corrolary of the old observatlon that the f lbr in cl-ots ln newborn olasma
are  more  t ransparant  (8 r9) .
Galanakis (10-12) emphasized the lmportance of the solvent condit ions,
especial ly of the lonic strength in the test ing systems. He found that
relat ivel-y high lonlc strengths prolong the thrombin clott ing t irne of cord
flbrinogen more than that of adult f ibr inogen. rn agreement with Gull l tn
(13) he found a slower rate and a lower degree of aggregatlon of fetal
f lbr in monomers as compared r^r i th adult f lbrtn monomers at high ionic
s t rength .
Teger-Nil-sson (14) found only a sltghtly 1-ower aggregation rate of fetal
f ibr in mononers and no signlf tcant prolongation of the thrornbin clott lng
time at a physiological lonlc strength and pH. This was also reported by
Krause (1,5). Teger-Nilsson found no dlf ferences between the two types of
f ibr inogen on polyacrylarnide gel electrophoresis and mapplng of tryptic
peptldes of reduced and a1-kylated polypeptLde chains.
Witt  and coworkers (3-9) described extensively the molecular propert ies of
puri f ied cord f ibr inogen. The overal l  aml,no aci-d composit ion of newborn
fibrinogen was virtual ly the same as that of adult f lbr inogen. On the basls
of data obtalne<l by f ingerprint ing tryptlc digests, she postulated that at
least three peptides dif fer in newborn as compared with adult f lbr lnogen.
Fetal f lbr inogen has been reported to contain the same amount of hexose,
but almost tw-ice the amount of phosphorus of adult f ibr inogen (5). This
probably did not explaln the functlonal dif ferences because enzynatlc
dephosphorylat ion dtd not correct the functional propert ies of fetal
f ibr inogen. On DEAE ce1lulose colrmn chromatography the rnaior f ibr inogen
peak from nevrborn f ibr inogen preDarations eluted somewhat later than those
obtained from adul-t  material.  The apparent K_ for thrombl-n was lower for
fetal- than for adult f ibr lnogen, sugglst ing amgreater aff ini ty of thrombin
for fetal than for adult f ibr inogen.
In 1979 Galanakis reported that part lal  removal of slal ic acid shortened
the prolonged thrombin clott lng t ime of fetal f ibr inogen. He found the
sial ic acid content of fetal f lbr inogen to be higher than that of adult
f lbr inogen (12). This was also reported by Lane, who descrlbed a rnarkedly
dif ferent carbohydrate composit ion of fetal f ibr inogen, part icularly an
lncreased s ia l i c  ac id  conten t  (16) .
Galanakis reported ln 1977 that a mixture of adult and fetal f ibr inogen is
found ln the cord plasma of ful l- term infants. In premature infants there
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l s  re la t l ve ly  more  fe ta l  f ib r lnogen (11) .
l , t111s and Karpatkln (17) chal lenged the existence of a dlst inct fetal
f ibr inogen. They concl-uded that the delay of clott ing of cord f ibr inogen is
due to a greater content of preformed f lbr in in these preparatLons and
could not relate the heterogeneity of adult f lbr inogen to the perslstance
of a fetal f lbr inogen.
Also other authors questloned the existence of a dist inct fetal f ibr inogen
( 1 8 , 1 9 , 2 0 ) .
Loly (21) could not f lnd any dif ference between adul-t  and fetal sheep-
f ibrinogen.
All togeiher there |s st l1l  a lot of controvetsy about the propert les of the
so cal l-ed fetal f lbr inogen and even l ts existence is doubted. Indeed the
varlat ions in experlmental results can be explained by dif ferences ln
purif icat lon methods and solvent condit ions in the test ing systems. Also
artefacts, introduced by l lmlted proteolysis in vltro cannot be precluded.
We therefore reexamined the problem under condLtions, where speclal care
was taken to prevent proteolysis in vitro.
We also rneasured the influence of adding increasing amounts of fragment X
to see whether the reported dif ferences between preparatLons of ne\^tborn and
aitult fibrlnogen could be explaLned by the presence of degradation products
in the former' 
T.,IATERTALS AND METH.DS
Blood samples were obtaineit from the urnblllicat cords of normal full-term
infaats by venapuncture, immediately after clamplng the urnbi l l ical cord.
The Apgar score of the lnfants was oore than 7 after one minute' the pH of
the nmbll l tcal vein blood greater than 7.20 and' the birth weights were al l
ln the nornal range. There were no sl-gns of fetal distress before
p a r t u r i t l o n  a n d  n o  m a c r o s c o p i c  a l t e r a t i o n s  o f  t h e  p l a c e n t a  a n d  t h e
urnbtl l ical cord were observed.
The mothers did not receive any medication, reported to Possibly lnf luence
the haeilostat ic reacti-on in the chi ld.
The f lrst fewmlrs of cord blood after a clean venapuncture were discarded.
The blood was then collected ln an antLcoagul-ant medir:m contaLning l%(w/w)
Na"  EDTA,  0 .92(w/w)  NaCl  and 400 K. I .u .  T rasy lo l  per  ml .  9  vo lumes o f  b lood
weie rnixecl with I volune of anticoagulant medlum.
Inrnediately after bloocl sampling 1 Z (v/v) di- isoptopylphosphofluoridate
(DFP) solut ion (0.1 M in dry isopropanol) was added to prevent proteolysls
vitro. The samples l^7ere centr i fugei l  fot 15 mlnutes at 1500 g in a swlng-out
rotor. The plasrna was centr i fuged at 20.000 g for twenty minutes to remove
blood platelets and other part lculate elements.
The plasrna was then di luted to 1.5 t imes the orlglnal blood voLurne with a
phos iha te  bu f fe r ,  0 .15  l { '  pH 7 .5 ,  con ta in ing  per  l i te r  22 .3  g t .  K2HP94 '  3
gr .  K I ITPO/  ,  1 .1  g r .  Na, -EDTA,  0 .1  g r .  NaN.  and 20 .000 K.  I .U .  Trasy lo l '  A t
each sfep-l  7'  (v/v) DFP'solut lon was addedi
Cord p1-asrnars of five newborns 1tere comblned to give a pool of approxl-
mately 100 rnl plasma and stored at -20'C untl-Ll further use. The cord
blood was obtaineat with the kind coiiperatlon of the staff of the Mldwivery
School in l leerlen (Head: Dr. R. Oomers).
l(lult blood was collected and plasma prepared frorn healthy donors as
described above.
Purif icat ion of Flbrinogen:
ffi were purifled frorn 100 n1 cord plasna and adult
plasma respectively, by the procedure to be i lescribed be1ow. The plasma was
applled to a Sepharose:lyslne co|:mn (2.8x13 cn) to remove plasmi-nogen. The
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e lua te  \ ras  b rought  to  257"  sa tura t ion  in  (NI { /  ) rSO/  (13 .9  g r . /100 n1) ,
st irred for one hour at 4 'C and centr l fuged for- fwen'ty minutes at 3000 g.
The preclpl-tate was dissol-ved ln phosphate buffer to 1.5 t lmes the ortginal
blood volume and again precipltated at 252 (NH/ )rS0/. saturation. This
preclpltate was dlssolved in a minimr:rn volume of f ,h5spfiate buffer and ge1
f i l te red  on  a  Sepharose 68  co lunn (2x120cm)  a t  4 'C .  The second peak
(absorbance at 280 nm) contains virtual- ly pure f ibr lnogen. Ihe purif lcat ion
procedure has been described ln detai l  elsewhere (Van Ruyven-Vermeer et a1.
22).
SDS polyacrylamlde gelelectrophoresis was performed accordlng to standard
procedure r^r l th and withoutf -rnercaptoethanol- (23).
Thrombin clott lng t ime: Fibrinogen concentrat ions were adjusted to 1 ng/m1-.
Al iquots of 0.200 ml f ibr lnogen solut ions were prelncubated for 30 seconds
at i7 oC. The reaction was started wtth 0.050 rn1 of a bovine thrombin
so l -u t ion  (5  N. I .H . / rn l ) (Roche,  Base l )  and the  c lo t t lng  tLme recorded w l th
the use of a Ko11e Hook.
The inf luence of the pTt of the f ibr inogen solut ions on the thrornbin
clott lng t irne was stui l ied by varylng the oI{ by dialysing before the
experiment against buffers contalning 0.15 M NaCl and 0.01 l ' {  Tris. Ionl-c
strengths r^rere varl ,ed in the range of 0.05 to 0.30 M NaCl at a constant pl l
7.4. The inf l-uence of eal-clurn added to the thrornbin solut ion was also
studied. To estlrnate the K_, the clott lng t lmes were obtained wlth
f ibrinogen sol-ut ions of dlf fet 'bnt concentrat lons.
Fragment X was prepared by l imited plasmin digestlon of puri f ied adult
f ibr inogen and purif ied accordlng to I^I.  Nieuwenhuizen and Gravesen (24).
Ttre effect of adding increasing amounts of fra$rent X on the thrornbin
clott ing t irne of cord and adult f ibr lnogen was studied, especial ly under
condit lons wlth a high pH and htgh ionlc strength.
C a r b o h y d r a t e  d e t e r r n l n a t i o n :  t h e  c a r b o h y d r a t e  a n a l y s e s  w e r e  p e r f o r m e d
essentlal ly as described by Karnerl- ing and Clarnp (25). Ihey were carr ied out
by  Drs .  J .P .  Kamer l lng ,  G.J .  Ger l lng  and J .F .G.  V l - iegenthar t ,  Labora tory  o f
Organlc Chenistry, Unlversity of Utrecht, Utrecht, Ihe Netherlands. Before
analysis sampl-es of f lbr lnogeo were run through a Biogel-P 60 colutnn in
0 .15  M NaCl ,  d la lysed ex tens ive ly  aga lns t  severa l  changes o f  d ls t l lLed
water and freeze-dried.
P h o s p h o r u s  d e t e r n l n a t l o n :  p h o s p h o r u s  d e t e r m l n a t i o n s  w e r e  c a r r l - e d  o u t
according to Bi i t tcher (26). Before analysis sampl-es of fetal and adult
f ibr inogen were dlalysed against several changes of twice-dist i l ted water
and freeze-dried. To check the possibi l l ty that the phosphorus ln the
flbrinogen orlginates from bound phosphol- lpids, the f lbr inogenpreparations
r\tere extracted according to the fol lowlng procedure: 2O ag port ions of
fetal- and adult f lbr inogen in l0n1 0.15 M NaCl were dialyzed against
d is t l l1ed  water  and f reeze-dr ied .
10 rnl NaCl (0.15 M) was also dlalyzed and freeze-drLed, to serve as a
control-.  To the residues 40 m1 rnethanol: chloroform = 1:2 was added and the
mlx tu te  heated  fo r  15  mlnu tes  a t  60 'C.  Mter  coo l lng  to  room tempera ture  9
ml 0.15 M NaCl was added to each tube and shaken wel1.
After centr i fugation to separate the phases, the upper layers were removed,
the bottono layers were washed once rrlth rnethanol-: chlorof orm: water =
48:4247 and centr i fuged again. The remainlng bottom layers were evaporated
under a stream of nitrogen, taken up ln 0.5 ml chloroform and the amount of
phospholtptds determlned accordlng to van cent (27).
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In contrast with sone reports ln the l i teraiure we found no sLgnif icant
dlf ferent infLuences of the pH and/or the ionic strength on the thronbln
clott lng t l-rne of adult and cord f ibr lnogen.
onry at high tonlc strength (0.30 M Nacl-) and htgh pl l  (9.0), the thrornbin
clott ing t lme seems to be sl ightly prol-onged rd-th cord as compared wrth
adult f lbr inogen. However, i t  is dtf f lcult  to decide how slgnlf icant these
d l f fe rences  are ,  sLnce t t  was  d i f f l cu l t  to  assess  the  c lo t t ing  t i rnes
accurately under these condit ions.
The pI{ optimum for the thrornbin-catalysed transltlon of both adult and cord
fibrlnogen to f lbr in was 7.4.
The K- values for the Lnteraction of thrombin (bovine) with adult and cord
f l b r l h o g e n  w e r e  d e t e r m l n e d  b y  m e a s u r i . n g  c l o t t l n g  t i m e s  w l t h  v a r y l n g
fibrinogen concentrat lons at a f lxed thrombln concentrat l-on. The results
are shown in figure 3. rn thls figure use has been made of the fact, that
the clott lng t lne ls proport lonal- to l /v (v = velocity of the overal_l
f lbr inogen conversion reaction in an experimental set up)(28). As can be
concluded from thts f igure, no blgnlf icant dlf ferences could be found
betweeri the K-ts of adult and cord f lbr inogen. The values found were 0.70
and 0. 62,p.M r$spectivel-y.
F igure  1 :
K for the interaction
wTth thrornbln (bovine)
f ibr lnogensolut ions 1n
the range of 0. I  to I
mg/n1 a t  pH 7 .4  anc l  0 .10
M NaCl  and 0 .010 M Tr ls .
t  = adult f ibr lnogen,
o = cord f ibr inogen
'/c ms/ml
ElectrophoresLs on SDS polyacrylarnlde gels containing .3 -mercapto-ethanol
showed no dif ference between adul-t  and cord fLbrinogen (not shown).
The carbohyilrate composltLons of cord fibrinogen and adult fibrlnogen are
essental l ly the same (tabte l)  and the resul_ts are in accordance with the
data of Tor.msend (29) for adult f ibr lnogen.
Differences in the sial ic acicl content, reported in the l i terature (12r16)
srere not confirned.
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TABLE I
A. Carbohydrate Compositlon of Adult anil Coril Flbrinogen
Vo l .32 ,  No .3
rnrol-. /rne molar ratio
Aa;[t- cord ;Effi-
malrnose 40.7 31.7 3.0
ga lac tose  25 .3  19 .5  1 .9
g lucose  10 .7  9 .9  0 .8
N-acetyl glucosamine 32.3 24.7 ?--4
s la l i c  ac ld  16 .5  14 .5  1 . . 2
cord
3 . 0
1 . 8
0 . 9
2 . 3
L . 4
We coulct conflrn that the phosphorus content ls 3 to 4 tfunes htgher in cord
flbrinogen than in adul"t fibrlnogen (5). ft could be excluded that his was
due to eontaminatLon with phospholipldS, because dfter li.ptd extractlon
virtualiy no phosphorus sras found in the extracts. The results are shown ln
tab le  2 .
TABLE 2
Phosphorus Content of Adult and Cot'd Flbrinogen (rnolar ratlo)
cord fibrLnogen:
adul-t flbrinogen:
P = 1 :  ( 1 0 . 9 + 0 . 2 ) .
P = 1 : ( 2 . 9 + - 0 . 4 ) .
r/c
sec
We a lso  s tud ied  the  ln f luence o f  ca lc ium on the  th fombln-ea td t l ysed
transitlon of flbrinogen to fl"brin. The results are shown ln figUre 2.
F igure  2 :
Effect of calcfi.m on the
thronbin clotting time
flbrinogen solut lons 1
rnglrnl at pH 7.4, 0.:15 I ' I
NaCl  an i l  0 .010 M Tr is
| = adult f lbr inogen,
, = cord fibrlnogea
Frorn this lt can be seen that the procoagulant effect of adtttng calcirgtr to
the thrombln solution is more pronounced in the pfeparations of cord-
flbrinogea than in those of adult fibrinogen.
some of the propert ies, ascribed to a dlsttnct fetal f ibr inogen specles,
night be explatned by the occurence of contamLnants, especial-ly flbrinogen
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breaki lown products, Ln some cord f lbr inogen preparations. These might have
been formed ln vlvo or ln vit to. We tr led to mlnlmLze f ibr inogen proteo-
lysis in vl-tro l-n our puri f lcatJ.on procedure.
No fibrlnogen degradation products were observed in our purlfted cord and
a d u l t  f l . b r i n o g e n  p r e p a r a t i o n s .  T h i s  l n d i c a t e s  t h a t  s u c h  d e g r a d a t i o n
products do not occur in vLvo in detectabl,e amounts or that they have been
lost durlng the purtf lcat ion of the f lbr inogen. fhe latter possibi l i ty
wouLd lead to a correction of the apDarent abnormall-ties observed with corcl
plasma as a result of the purif icat ion.
The occurence of degradation products Ln newborn blood ln vl-vo ls l lkely,
slnce lt is knonn that ln the slck newborn a marked ilegree of dlffuse
intravascular coagul-ation ls quite corunon, probabl-y related to hypotension,
hypothenoia, hypoxla, acldosis, poor t lssue perfuslon, hepatic lmmaturl ty
and a poorly developped retlculo endothel-la1 system, whlch may prevent
adequate clearing of act ivated coagulat ion factols and therefore enhance
the sequala of dif fuse LntravascuLar coagulat ion.
The enhanced fibrtnolytlc capacity of cord blood of normal newborns ls well-
documented in the l i terature (30) anit  may be the cause of some proteolysis
of f ibr inogen.
If  demonstrated, the presence of i legradatLon products Ln cord plasma could
explal-n sone of the propert ies, ascrlbed to fetal f ibr inogen. I t  ls knor.m,
that fragment X, for l-nstance is a potent inhibitor of the actlon of
thrombin on flbrinogen and polym.erlzatlon of fibrin mononers (24). In
nearly al- l  newborn cord pLasmat s the thronobLn clott t lng t lne is prolonged.
Aceorcl lng to our data, this prolongation cannot be attr ibuted to i lLfferent
c l o t t i n g  p r o p e r t l e s  o f  p u r i f l e d  c o r d  f i b r l - n o g e n ,  b u t  r n i g h t  w e l l  b e
explained by the presence of for instance fragment X. As At this time no
specif lc and senslt ive methods are aval lable to demonstrate the presence of
Low 1eve1s of some of the hlgh rnoLecular weight breakdown proddcts dlrectly
ln plasma, we studied the lnfluence of lncreasing amounts of added fragment
X to the sol-ut lons of puri f ied f ibr inogens, especial ly under condlt lons
wlth a high plf  and high lonic strength.
F lgure  3 :
Effect of fragnent X at high
pl l ,  f lbr lnogen solut ions
I  mg/m1,  0 .15  1"1  NaCl  ,  0 .010 M
Tris, pl l  9
I = adult f lbr inogen
O = cord f ibr lnogen
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Figrrre 4:
etfect of fragment X at high
i o n i c  s t r e n g t h ,  f i b r i n o g e n
solut ions I rng/ml, 0.30 I ' t  NaCl'
0 . 0 1 0  M  T r l s ,  P I {  7 . 4
?= adult f ibr inogen
a= cord f ibr inogen
As can be seen in figure 3, the thrombln clotting time of cord flbrlnogen
appeared to react ,i.o.rg"i to the addltlon of fragment x 
than adult
tiirtnogen at pl{ 9. No differences were recordeil between the tlto 
types of
fibrinoien at Ltgh ionic strength, when Lncreasing amounts of 
fragment X
were added to the flbrLnogen eolutions,
Thls ls shown in ftgure 4.
These fesults suggegt that some of the clott ing propert les, ascribed 
l .n the
i l i . r . t " . "  to  i " " t " f  f ib r inogen may be  due to  a  contaml -na t ion  
w i th
degrailatlon products such as fragment X.
Wiia-p."a"l-ateal (9) that the synthesis of fetal f l -br1nogen 
lasts only for
j-g d"y" after birth. We suggest, that after that period the f lbr in-
(ogen)oiysts has returned to t tJrt" i  levels and that degradation products
"rrlh 
." lragrnent X have been cl-eared frorn the newborn btooil.
our results clearly confirm the higher phosphorus content 
ln purlfied cord
f l b r l n o g e n t h a n l r r a d u l t f l b r i n o g e n . L t t t l e o r n o t h i n g l s k n o v m a b o u t t h e
role of phosphorus ln the f ibt lnogen molecule'
B t o n b a c k ( 3 1 ) s h o w e d t h a t t h e p h o s p h o r u s i n a d u l t f l b t i n o g e n l s c o v a l e n t l y
bound in the .forrn of o-phosphoserlne and partly formd in flbrlnopeptiile 
A'
Accordlng to the data of witt enzyroatlc dephosphorylatlon had no 
effect on
the  func t lona l  ProPer t tes  (5 ) .
T h e h l g h e r p h o s p h o r u s c o n t e n t r n a y p l a y a r o l e l n t h e t r r o r e p r o n o u n c e d e f f e c t
of cal-cturn .aa"a to the thrombln solutl-on, on the thrombin clotting 
tlme ln
purifred cord f lbr inogen as compafed with adult f ibr inogen. At 
pfesent
expefiments are cagiei out to f tnd possible cortelafLons between 1eve1s 
of
plasnlnogen actLvators ancl prolonged thrornbin clotting tlrnes of cord 
plasna
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